Evidence map›Paper›PMID 25939511›Full record

ArticleInfection and immunity2015

Type 3 Secretion System Island Encoded Proteins Required for Colonization by Non-O1/non-O139 Serogroup

Mudit Chaand, Kelly A Miller, Madeline K Sofia, Cory Schlesener, Jacob W A Weaver, Vibha Sood, Michelle Dziejman

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. VopX, a novelmBio · 2025
    Article
  4. Article
  5. Public health aspects ofEFSA journal. European Food Safety Authority · 2024
    Article
  6. Non-O1/Non-O139Microorganisms · 2024
    Review
  7. Article
  8. Article
  9. ToxigenicApplied and environmental microbiology · 2023
    Article
  10. Article
  11. Microbial genomics · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Virulence Regulation and Innate Host Response in the Pathogenicity ofFrontiers in cellular and infection microbiology · 2020
    Review
  19. Non-O1, Non-O139Infection and drug resistance · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mudit ChaandDepartment of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY.
Kelly A MillerDepartment of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY.
Madeline K SofiaDepartment of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY.
Cory SchlesenerDepartment of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY.
Jacob W A WeaverDepartment of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY.
Vibha SoodDepartment of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY.
Michelle DziejmanDepartment of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY michelle_dziejman@urmc.rochester.edu.
University of Rochester · US

Funding

INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
Resource in Education in Microbiology and ImmunologyR25GM064133 · NIGMS · UNIVERSITY OF ROCHESTER · PI LORD, EDITH M · 2002 to 2017
$4.2M
Training in Microbial PathogenesisT32AI007362 · NIAID · UNIVERSITY OF ROCHESTER · PI IGLEWSKI, BARBARA H. · 1990 to 2010
$2.6M
Infection and Immunity: The Pathogenesis of Host-Microbe InteractionsT32AI118689 · NIAID · UNIVERSITY OF ROCHESTER · PI Paul M. Dunman, BRIAN M WARD · 2015 to 2026
$2.5M
Pathogenic mechanisms of non-01/non-0139 V. choleraeR01AI073785 · NIAID · UNIVERSITY OF ROCHESTER · PI DZIEJMAN, MICHELLE · 2008 to 2012
$1.9M
Pediatric Research: Bench to Bedside to CurbsideT32HD057821 · NICHD · UNIVERSITY OF ROCHESTER · PI SCHOR, NINA F · 2010 to 2014
$1.1M
NIAID NIH HHS R01 AI073785NIAID NIH HHS T32 AI007061NIAID NIH HHS T32 AI007362NIAID NIH HHS T32 AI118689NICHD NIH HHS T32 HD057821NIGMS NIH HHS R25 GM064133
6 · The paper itself

Abstract

Vibrio cholerae is a genetically diverse species, and pathogenic strains can encode different virulence factors that mediate colonization and secretory diarrhea. Although the toxin co-regulated pilus (TCP) is the primary colonization factor in epidemic causing V. cholerae strains, other strains do not encode TCP and instead promote colonization via the activity of a type three secretion system (T3SS). Using the infant mouse model and T3SS-positive O39 serogroup strain AM-19226, we sought to determine which of 12 previously identified, T3SS translocated proteins (Vops) are important for host colonization. We constructed in frame deletions in each of the 12 loci in strain AM-19226, and identified five Vop deletion strains, including ΔVopM, which were severely attenuated for colonization. Interestingly, a subset of deletion strains was also incompetent for effector protein transport. Our collective data therefore suggest that several translocated proteins may also function as components of the structural apparatus or translocation machinery, and indicate that while VopM is critical for establishing an infection, the combined activities of other effectors may also contribute to the ability of T3SS-positive strains to colonize host epithelial cell surfaces.

Identifiers

PMID25939511
PMCPMC4468554
OpenAlexW2110976424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.